Instil Bio, Inc. (TIL) Financials

TIL Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 200.4 million 89.7 million
Dec. 31, 2025 203.5 million 89.7 million
Sept. 30, 2025 211.8 million 91.3 million
June 30, 2025 231.0 million 99.3 million

TIL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.3 million 985000
Dec. 31, 2025 -7.1 million 1.6 million
Sept. 30, 2025 -10.6 million 1.8 million
June 30, 2025 -14.8 million 1.8 million

TIL Net Income

No data available :(

TIL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 74.6 million - -
Dec. 31, 2025 76.1 million 84.8 million 372000
Sept. 30, 2025 79.7 million 84.6 million 305000
June 30, 2025 91.8 million 84.4 million 462000

TIL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 6.8 million
Dec. 31, 2025 6.8 million
Sept. 30, 2025 6.8 million
June 30, 2025 6.6 million

TIL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 669000 5.3 million -
Dec. 31, 2025 - 3.5 million 6.1 million -
Sept. 30, 2025 - 9.1 million 5.9 million -
June 30, 2025 - 6.7 million 6.2 million -

TIL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 12000
Dec. 31, 2025 - 12000
Sept. 30, 2025 - 12000
June 30, 2025 - 12000

TIL

Price: $8.23

52 week price:
5.67
42.79

Earnings Per Share: -10.70 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 566200

Ebitda: -268970

Market Capitalization: 54.7 million

Links: